SCHEMBL2404093

SCHEMBL2404093

Cc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@H](C(=O)N2CCN(C(C)C)CC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.50
HSD11B1 P28845 1/20 0.46
DPP4 P27487 7/20 0.44
DPP7 Q9UHL4 5/20 0.44
KCNH2 Q12809 4/20 0.44
DPP8 Q6V1X1 3/20 0.43
DPP9 Q86TI2 3/20 0.43
CCR8 P51685 2/20 0.43
HRH3 Q9Y5N1 1/20 0.43
DRD2 P14416 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
MEP1B Q16820 1/20 0.39
BRD4 O60885 1/20 0.39
BRD2 P25440 1/20 0.39
BRD3 Q15059 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2404095 1.00 USP30 (0.50) USP30HSD11B1DPP4DPP7KCNH2
SCHEMBL2405892 1.00 USP30 (0.50) USP30HSD11B1DPP4DPP7KCNH2
SCHEMBL2405224 0.92 DPP4 (0.46) USP30DPP4DPP7KCNH2DPP8
SCHEMBL2405223 0.92 DPP4 (0.46) USP30DPP4DPP7KCNH2DPP8
SCHEMBL2402954 0.89 DPP4 (0.56) DPP4DPP7KCNH2DPP8DPP9
SCHEMBL2402947 0.89 DPP4 (0.56) DPP4DPP7KCNH2DPP8DPP9
SCHEMBL2401720 0.85 CCR8 (0.52) HSD11B1DPP4DPP7KCNH2CCR8
SCHEMBL2401724 0.85 CCR8 (0.52) HSD11B1DPP4DPP7KCNH2CCR8
SCHEMBL2401696 0.84 L3MBTL1 (0.50) HRH3DRD2ADRA1DADRA1AADRA1B
SCHEMBL2401700 0.84 L3MBTL1 (0.50) HRH3DRD2ADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017773-B2 Cyclohexyl sulfonamide derivatives HOFFMANN-LA ROCHE INC. (US) 2011-09-13 US disclosed
EP-1979322-B1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HAVING H3 RECEPTOR ACTIVITY HOFFMANN LA ROCHE (CH) 2010-09-01 EP disclosed
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES NETTEKOVEN MATTHIAS 2010-05-13 US disclosed
US-20070173511-A1 Cyclohexyl sulfonamide derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HRH3, HRH4, HRH1 USP30 2563/4885HSD11B1 1268/4885DPP4 1782/4885
US-20070173511-A1 Cyclohexyl sulfonamide derivatives HRH3, HRH4, HRH1 USP30 2563/4885HSD11B1 1268/4885DPP4 1782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.